Figure 3.
Cumulative metastasis-free survival of patients with high CD155 expression levels compared with patients with low expression levels in soft tissue sarcoma. Kaplan-Meier curves demonstrated that there were no statistically significant differences in the metastasis-free survival rates between the patients with higher expression levels of CD155 and those with lower expression levels.